NYSE: XPEVXpeng Inc Stock
$28.07+2.03 (+7.8%)
Updated Nov 11, 2025
XPEV Price
$28.07
Fair Value Price
N/A
Market Cap
$26.70B
52 Week Low
$11.14
52 Week High
$28.24
P/E
-44.98x
P/B
6.35x
P/S
2.03x
PEG
N/A
Dividend Yield
N/A
Revenue
$8.36B
Earnings
-$595.20M
Gross Margin
15.7%
Operating Margin
-6.53%
Profit Margin
-7.1%
Debt to Equity
2.05
Operating Cash Flow
N/A
Beta
1.56
Next Earnings
Nov 13, 2025
Ex-Dividend
N/A
Next Dividend
N/A
XPEV Overview
XPeng Incorporated designs and manufactures electric vehicles in China. It offers SUVs under the G3 and G3i names; sports sedans under the P7 name; and smart electric vehicles and family sedans under the P5 name. The company also provides EV maintenance services, super-fast charging, vehicle leasing, an insurance agency, a ride-hailing platform, technical support, automotive loan referrals and financing, music subscriptions, and other services. XPeng was founded in 2015 and is headquartered in Guangzhou, PRC.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine XPEV's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Auto
Industry Rating
F
XPEV
Ranked#5 of 27
Ranked#5 of 27
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $50.75 | A | |
| $71.22 | C | |
| $28.04 | C |
Be the first to know about important XPEV news, forecast changes, insider trades & much more!
XPEV News
Overview
Due Diligence Score
–
Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how XPEV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
XPEV is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
XPEV is poor value based on its book value relative to its share price (6.35x), compared to the US Auto Manufacturers industry average (3.48x)
P/B vs Industry Valuation
XPEV is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more XPEV due diligence checks available for Premium users.
Valuation
XPEV price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-44.98x
Industry
186.1x
Market
46.18x
XPEV price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
6.35x
Industry
3.48x
XPEV is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
XPEV's financial health
Profit margin
Revenue
$2.5B
Net Income
-$66.4M
Profit Margin
-2.6%
XPEV's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$12.9B
Liabilities
$8.6B
Debt to equity
2.05
XPEV's short-term assets ($7.60B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
XPEV's short-term assets ($7.60B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
XPEV's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
XPEV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
XPEV vs Auto Stocks
Xpeng Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.